SanBio Company Limited provided consolidated earnings guidance for the fiscal year ended January 31, 2021. For the period, the company expects operating loss of JPY 5,453 million, net loss attributable to owners of the parent of JPY 5,544 million and net loss per share of JPY 107.06.